BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 25911656)

  • 1. Polycyclic aromatic hydrocarbons: from metabolism to lung cancer.
    Moorthy B; Chu C; Carlin DJ
    Toxicol Sci; 2015 May; 145(1):5-15. PubMed ID: 25911656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer.
    Stading R; Gastelum G; Chu C; Jiang W; Moorthy B
    Semin Cancer Biol; 2021 Nov; 76():3-16. PubMed ID: 34242741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
    Shimada T; Guengerich FP
    Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism.
    Wohak LE; Krais AM; Kucab JE; Stertmann J; Øvrebø S; Seidel A; Phillips DH; Arlt VM
    Arch Toxicol; 2016 Feb; 90(2):291-304. PubMed ID: 25398514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.
    Kondraganti SR; Fernandez-Salguero P; Gonzalez FJ; Ramos KS; Jiang W; Moorthy B
    Int J Cancer; 2003 Jan; 103(1):5-11. PubMed ID: 12455047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons.
    Shimada T
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):257-76. PubMed ID: 16946553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxic polycyclic aromatic hydrocarbon ortho-quinones generated by aldo-keto reductases induce CYP1A1 via nuclear translocation of the aryl hydrocarbon receptor.
    Burczynski ME; Penning TM
    Cancer Res; 2000 Feb; 60(4):908-15. PubMed ID: 10706104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of aryl hydrocarbon receptor in regulation of enzymes involved in metabolic activation of polycyclic aromatic hydrocarbons in a model of rat liver progenitor cells.
    Vondrácek J; Krcmár P; Procházková J; Trilecová L; Gavelová M; Skálová L; Szotáková B; Buncek M; Radilová H; Kozubík A; Machala M
    Chem Biol Interact; 2009 Jul; 180(2):226-37. PubMed ID: 19497421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to polycyclic aromatic hydrocarbons: bulky DNA adducts and cellular responses.
    Henkler F; Stolpmann K; Luch A
    Exp Suppl; 2012; 101():107-31. PubMed ID: 22945568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
    Cavalieri E; Rogan E
    Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase.
    Burczynski ME; Lin HK; Penning TM
    Cancer Res; 1999 Feb; 59(3):607-14. PubMed ID: 9973208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53.
    Yu D; Berlin JA; Penning TM; Field J
    Chem Res Toxicol; 2002 Jun; 15(6):832-42. PubMed ID: 12067251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells.
    Palackal NT; Lee SH; Harvey RG; Blair IA; Penning TM
    J Biol Chem; 2002 Jul; 277(27):24799-808. PubMed ID: 11978787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
    Shultz CA; Quinn AM; Park JH; Harvey RG; Bolton JL; Maser E; Penning TM
    Chem Res Toxicol; 2011 Dec; 24(12):2153-66. PubMed ID: 21910479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human aldo-keto reductases and the metabolic activation of polycyclic aromatic hydrocarbons.
    Penning TM
    Chem Res Toxicol; 2014 Nov; 27(11):1901-17. PubMed ID: 25279998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of (+/-)-benzo[a]pyrene-trans-7,8-dihydrodiol activation by human cytochrome P450 and aldo-keto reductase enzymes: effect of redox state and expression levels.
    Quinn AM; Penning TM
    Chem Res Toxicol; 2008 May; 21(5):1086-94. PubMed ID: 18402469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
    Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
    Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1.
    Shimada T; Fujii-Kuriyama Y
    Cancer Sci; 2004 Jan; 95(1):1-6. PubMed ID: 14720319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic enzyme induction by HepG2 cells exposed to oxygenated and nonoxygenated polycyclic aromatic hydrocarbons.
    Misaki K; Matsui S; Matsuda T
    Chem Res Toxicol; 2007 Feb; 20(2):277-83. PubMed ID: 17253728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urban dust particulate matter alters PAH-induced carcinogenesis by inhibition of CYP1A1 and CYP1B1.
    Courter LA; Musafia-Jeknic T; Fischer K; Bildfell R; Giovanini J; Pereira C; Baird WM
    Toxicol Sci; 2007 Jan; 95(1):63-73. PubMed ID: 17060372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.